Pnc Financial Services Group, Inc. Tyme Technologies, Inc. Transaction History

Pnc Financial Services Group, Inc.

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 12, 2022	BUY	$0.23 - $0.35 $5,750 - $8,750	25,000 New	25,000 $7,000
Q2 2021 Aug 06, 2021	SELL	$1.14 - $1.87 $478 - $785	-420 Closed	0 $0
Q1 2019 May 10, 2019	BUY	$1.76 - $3.73 $739 - $1,566	420 New	420 $0

Ticker TYME
Exchange NASDAQ
Shares Outstandng 172,207,008
Description
Tyme Technologies, Inc., a biotechnology company, develops cancer metabolism-based therapies (CMBTs) in the United States. Its lead drug product is SM-88, a CMBT that is in a Phase II/III clinical trial to treat across 15 types of cancer, including pancreatic, prostate, breast, lung, glioma, ovarian, sarcoma, and colon. The company is also devel...

Get notified when there are updates to the investment portfolio of Pnc Financial Services Group, Inc., based on Form 13F filings with the SEC.

Stay updated on Pnc Financial Services Group, Inc. with notifications on news.